key: cord-0899318-rqvkh0yo authors: Rousseau, M.-C.; Hully, M.; Milh, M.; Juzeau, D.; Pollez, B.; Peudenier, S.; Bahi Buisson, N.; Gautheron, V.; Chabrol, B.; de Villemeur, T. Billette title: Clinical characteristics of COVID-19 infection in polyhandicapped persons in France date: 2021-04-24 journal: Arch Pediatr DOI: 10.1016/j.arcped.2021.04.004 sha: 1c6f04910af7faa9a4cf7263b3645efc67314ca2 doc_id: 899318 cord_uid: rqvkh0yo Aim: Little is known about the clinical profile of COVID-19 infection in polyhandicapped persons. This study aimed to describe the characteristics of this infection among individuals with polyhandicap. Method: This was a retrospective observational study. Polyhandicap was defined by the combination of motor deficiency, profound mental retardation, and age at onset of cerebral lesion younger than 6 years. A positive COVID-19 status was considered for patients with a positive COVID-19 laboratory test result, or patients presenting with compatible symptoms and living in an institution or at home with other patients or relatives who had laboratory-confirmed COVID-19 infection. Data collection included sociodemographic data, clinical and paraclinical characteristics, as well as the management and treatment for COVID-19 infection. Results: We collected 98 cases, with a sex ratio of 0.98 and a mean age of 38.5 years (3 months to 73 years). COVID-19 infection was paucisymptomatic in 46% of patients, 20.6% of patients presented with dyspnea, while the most frequent extra-respiratory symptoms were digestive (26.5%) and neurological changes (24.5%); 18 patients required hospital admission, four adults died. The mean duration of infection was longer for adults than for children, and the proportion of taste and smell disorders was higher in older patients. Conclusion: These findings suggest that PLH persons often develop paucisymptomatic forms of COVID-19 infection, although they may also experience severe outcomes, including death. Clinicians should be aware that COVID-19 symptoms in PLH persons are often extra-respiratory signs, mostly digestive and neurologic, which may help in the earlier identification of COVID-19 infection in this particular population of patients. Polyhandicap (PLH), as a recently defined concept [1] [2] [3] , is a serious health condition with severe and complex disabilities corresponding to a chronic disorder occurring in an immature brain, which leads to a combination of profound intellectual disability and serious motor disorder and results in an extreme restriction of autonomy and communication. These neurological, intellectual, and motor disabilities are frequently accompanied by sensory deficits and behavioral and relational disorders. This term is similar to the notion of "profound intellectual and multiple disabilities," which is used in other countries but does not systematically refer to a disorder affecting an immature brain [4] . The prevalence of polyhandicap in France is estimated to be between 0.7 and 1.28 per thousand, i.e., 880 new cases of children with polyhandicap per year [5] [6] [7] . Persons with PLH have numerous comorbidities, and the main cause of death among these patients is respiratory failure after recurrent pulmonary infections resulting from a combination of different factors (including scoliosis with thoracic deformation, swallowing disorders, gastroesophageal reflux disease, insufficient bronchial drainage measures, and transit disorders, etc.) [8] [9] [10] [11] [12] . Since the beginning of the COVID-19 pandemic, a variety of manifestations have been reported both in adults and children, and a greater frequency of complications and death from COVID -19 infection has been widely documented in patients with chronic pathologies and comorbidities as well as in people over 70 years of age [13] . It is therefore reasonable to study the consequences of COVID-19 infection in polyhandicapped patients. This issue led a group of physicians in France specializing in polyhandicap to conduct an observational study on COVID-19 infection in this population of patients so as to identify the specific characteristics of the infection among patients with polyhandicap (respiratory and extra-respiratory symptoms) and the occurrence of complications (severe forms) and death. These findings will help medical teams perform a prompt diagnosis of this infection and optimize their care management and hospital discharge as most of these patients live in nonmedicalized institutions and sometimes at their parents' homes. The aim of this study was to describe (i) the clinical profile of the COVID-19 infection and (ii) the occurrence of complications and death in this fragile population of patients. Data were collected retrospectively through a questionnaire form that was sent to practitioners working in specialized institutions and rehabilitation centers for PLH persons and to practitioners of pediatric/neurologic university hospitals. Practitioners retrieved information from the patient files and answered the questionnaire with the information they obtained. We chose to target people with polyhandicap defined by the combination of motor deficiency (quadriplegia, hemiparesis as a predominant hemibody motor impairment, diplegia, extrapyramidal syndrome, cerebellar syndrome, and/or neuromuscular problems) and severe/profound mental impairment (intelligence quotient <40; for patients older than 5 years: IQ= developmental age below 2 years old; for children 3-5 years old: IQ= developmental quotient <40% or not assessable) associated with everyday life dependence (Functional Independence Measure <55) and restricted mobility (Gross Motor Function Scale [GMFCS and GMFCS-ER], III, IV and V [14] ) with age at onset of cerebral lesion below 6 years. -19 infection confirmed by laboratory tests, or if a patient with compatible symptoms for COVID-19 lived with relatives (parents, siblings) who had a diagnosis of laboratory-confirmed COVID-19 infection (in accordance with the French Health Policy recommendations) . The parents and/or legal representative received written information on this observational study, and their non-opposition to the use of their child's health data was collected. This study followed the STROBE guidelines. The following patient characteristics at baseline were collected: Sociodemographic data: gender, age, type of care (specialized rehabilitation centers, residential facility, or home care), and geographic area. The paraclinical features (imaging and blood tests) of COVID-19 infection in polyhandicapped patients: findings on chest X-rays (lobe consolidation, diffuse bronchial infiltration). Occurrence of ground-glass opacities on chest computerized tomography (CCT) [15] . Abnormal blood test results (lymphocytopenia, neutropenia) and higher Creactive protein (CRP) levels were observed during COVID-19 infection. Therapies and care management of COVID-19 infection: main treatment prescribed (antibiotic treatment, hydroxychloroquine, oxygen therapy) and the need for noninvasive mechanical ventilation. Care management: transfer to a medicalized structure (hospital discharge, admission to an intensive care unit [effective or required but declined]). Patient outcome after COVID-19 infection: death or deterioration of health status defined by weight loss. Comparisons were made between patients under and over 50 years of age since in the general population people aged over 50 are considered at higher risk of a severe outcome after COVID-19 infection (https://www.has-sante.fr/jcms/p_3240076/fr/covid-19-quelsleviers-pour-vacciner-plus-vite-les-personnes-les-plus-vulnerables). Regulatory monitoring was performed according to the French law that requires the approval of the French ethics committee (Comité d'éthique de la recherche de la Société Française de Pédiatrie: CERSFP_2020_118). This study was registered on the AP-HM anonymous health data portal, PADS20-108. Statistical analyses were performed using SPSS software (IBM SPSS PASW Statistics Inc., Chicago, IL, USA). Qualitative variables are presented as number and proportion for the two groups. Quantitative variables are presented as mean, standard deviation, median, and 25th and 75th percentiles. Depending on the distribution of the variables, chi-squared or Fisher's exact tests were used for qualitative variables. Comparisons between the two groups were made with the usual tests (Student's t test, ANOVA) and nonparametric tests (Mann-Whitney, Kruskal-Wallis) according to the applicability of these different tests. Between April 1, 2020 and July 1, 2020, we collected a total of 98 questionnaire forms from patients who met the COVID-19 criteria. The first cases of COVID-19 occurred in March 2020, and the last cases occurred in June 2020. The diagnosis of COVID-19 infection was based on (i) laboratory tests for 79.6% of the patients, (ii) cluster of institutionalized patients as defined previously for 17.3% of the patients, and (iii) home cluster for 3.1% of the patients. Etiologies of polyhandicap were unknown for 30.6% of the cases. Among the known etiologies, 48.4% (n=33) were constitutional: 4.4% (n=3) of the patients presented with central nervous system malformations, 35.2% (n=24) of the patients presented with neurometabolic or neurogenetic diseases, 8.8% (n=6) of the patients presented with epileptic encephalopathy, and 51.6% (n=35) presented with an acquired disease (see Table 1 for details). J o u r n a l P r e -p r o o f 9 The frequency of associated comorbidities in decreasing order was as follows: epilepsy 56.1% (n=55), swallowing disorders 40.8% (n=40), scoliosis 16.3% (n=16), gastroesophageal reflux 13.4% (n=13), and recurrent pulmonary infections 6.1% (n=6). Overall, 12.2% (n=12) received enteral nutrition and 5.1% (n=5) received baseline respiratory treatments (see Table 1 for details). COVID-19 infection was paucisymptomatic in 46% of the patients (n=45), and all of them had a positive PCR result. Fever was the most constant symptom (68.4%; n=67). The most frequent respiratory symptoms were dyspnea (20.6%, n=20), hypoxemia (28.9%, n=28), and bronchial congestion (21.6%, n=21). The most frequent extra-respiratory symptoms were digestive symptoms (diarrhea/vomiting) 26.5% (n=26), followed by neurological symptoms, modification of consciousness and/or behavior 24.5% (n= 24), difficulty with taste and smell 11.8% (n=10), and increased epileptic seizures or epileptic seizures appearing in nonepileptic patients, 1% (n=3). See Table 2 for details. Only 9.8% (n=8) of the patients had a chest X-ray (the main radiologic abnormalities were lobe consolidation or diffuse infiltration), and only 12.5% (n=10) of the patients had CCT, showing specific COVID-19 changes in all cases. The main laboratory abnormalities were, in decreasing order, elevated C-reactive protein (CRP) levels, lymphopenia and neutropenia (see Table 2 for details). The main treatment modalities for COVID-19 infection were antibiotic treatments in 36 patients (37.1% of cases), and the most frequently used antibiotic was azithromycin; one third of the patients received oxygen therapy, and only two patients needed noninvasive mechanical ventilation. Table 2 for details). There was no significant difference in patient gender in terms of general health characteristics, comorbidities, therapies and care management, and patient outcomes. COVID-19 symptoms did not differ by gender except for digestive troubles, which were significantly more frequent in girls than in boys (see Table 3 for details). There was no significant difference between children and adults and between older and younger patients for general health characteristics, comorbidities, COVID-19 symptoms, therapies, and care management. The mean duration of COVID-19 infection was significantly longer for adults than for children, and the proportion of taste and smell disorders was significantly higher in older (over 50 years old) than in younger patients (see Tables 4 and 5 for details). Despite was similar to the proportion reported in previous studies, which ranged from 15 to 60% [2] . Our population of patients had a high prevalence of specific comorbidities, such as epilepsy as well as scoliosis with thoracic deformation and swallowing disorders inducing respiratory problems, which are identified as risk factors for poor outcomes of COVID-19 infections [16] . Not surprisingly, the patients came from the French geographic areas most affected by the epidemic (northern and central and south-eastern), and most patients were cluster cases in institutional settings. The first interesting finding is that the course of the disease was mild in 46% of PLH persons. This fact is surprising and unexpected in this fragile population with deteriorated health conditions and numerous associated comorbidities. Despite the nationwide character of this study, we report a limited number of pediatric cases, which is consistent with published data reporting that children are less likely to be symptomatic or to develop severe symptoms compared with adults [17] . The main symptom of COVID-19 infection in PLH patients was fever (almost 70% of cases), and a quarter of the patients presented with respiratory symptoms. A quarter of the patients presented with extra-respiratory symptoms (digestive [diarrhea, vomiting] and neurologic [altered state of consciousness or behavioral modifications, and epilepsy]), whereas cutaneous disorders were found in only 5% of the patients. We observed some similarities between COVID-19 clinical features in PLH and older patients such as paucisymptomatic expression and digestive symptoms [18] . The low proportion of smell and taste disorders (12%) may be explained by under/misdiagnosis, which was due to the very low communication ability of the patients, making their evaluation challenging. We did not find any gender difference for the severe forms of COVID-19 infection in PLH patients. These results differ from results reported for the general population, which usually show a higher proportion of severe forms in men [19] . The only difference observed for COVID-19 symptoms between the genders was an unexplained higher proportion of digestive symptoms in women (35.4%). We did not observe any differences in the clinical characteristics of COVID-19 infection across children and adults or between younger and older patients, except for a higher proportion of taste and smell disorders in older patients and a longer duration of COVID-19 infection in adults compared with children, which is consistent with the findings of previous studies reporting that children often have COVID-19 infection with low-to-moderate symptoms [17] . Although aging is associated with severe forms of COVID-19 infection, we did not find any difference between younger/children and older/adult patients for the severe symptoms of COVID-19 infection. However, all fatal cases in our study were adults; but the mean young age of our patients (38 years) may partly explain the relatively "low frequency" of fatalities in this fragile population of patients. Another explanation may be that older PLH patients do not have exposure to certain cardiovascular and cancer risk factors (tobacco and alcohol) and have a very low incidence of chronic diseases such as cancer, diabetes, and cardiovascular diseases [20] . Previous studies have found that people with intellectual disability had poorer COVID-19 outcomes [21] ; in fact, our results reveal that nearly 20% of patients needed hospital admission for respiratory symptoms corresponding to severe forms of COVID-19 infections, and 5% developed critical disease with resuscitation offered. Four patients in our study died of COVID-19 infection, all of whom were adults; surprisingly, they did not present with pulmonary comorbidities at baseline. The case fatality rate of COVID-19 infection among PLH persons in our study was lower (4%) than the death rate among people with intellectual or developmental disability, varying from 5% in the United States (New patient outcome, with a median duration of COVID-19 infection of 9 days, and a significant proportion of patients (40%) presented with weight loss after the infection. This study shows that PLH patients are vulnerable to COVID-19 infection and should therefore be considered at high risk of severe forms of COVID-19, and appropriate measures should continue to be taken to protect them. The low mortality of COVID-19 infection in our population of PLH patients suggests that hospital care management is useful in these patients with severe forms. This outcome does not exclude the question of the level of management adapted to each patient on a case-by-case basis. As previously demonstrated for children with physical disabilities, it is important to maintain the medical care and rehabilitation adapted to the complex needs of PLH persons during this health crisis in order to prevent increased health deterioration [22] . The present study has several limitations. First, our analysis was based on a retrospective study, which might lead to bias and limit the generalizability and reliability of our results. Second, our results do not represent the general population of PLH patients but instead represent mostly patients cared for in institutions, as we could not make contact with all practitioners specializing in polyhandicap in France. The findings of this study suggest that PLH persons often develop paucisymptomatic forms of COVID-19 infection, although they may also have severe outcomes, including death. Clinicians should be aware that the presenting symptoms of COVID-19 in PLH persons are often extra-respiratory signs, mostly digestive and neurologic, which may help in the earlier identification of COVID-19 infection in this particular population of patients. Adequacy of care management of patients with polyhandicap in the French health system: A study of 782 patients Le parcours de santé de l'enfant polyhandicapé Impact of caring for patients with severe and complex disabilities on health care workers' quality of life: determinants and specificities A need for a taxonomy for profound intellectual and multiple disabilities Définition et prévalence des polyhandicaps à l'âge scolaire Enquête Handicaps-Incapacités-Dépendance en institution en Enquête épidémiologique sur les enfants polyhandicapés du département du Nord Aetiologies, comorbidities and causes of death in a population of 133 patients with polyhandicaps cared for at specialist rehabilitation centres Le décès des patients polyhandicapés: l'expérience du service de pédiatrie spécialisée pour polyhandicapés de La Roche-Guyon Survival rates of children with severe neurologic disabilities: a review Acute respiratory distress syndrome in children with severe motor and intellectual disabilities Pathological study of bronchospasms/tracheomalasia in patients with severe motor and intellectual disabilities Coronavirus : qui sont les personnes fragiles ? Content validity of the expanded and revised Gross Motor Function Classification System Chest computed tomography findings of coronavirus disease 2019 (COVID-19) pneumonia Prognosis in severe motor and intellectual disabilities syndrome complicated by epilepsy Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children COVID-19 in seniors: Findings and lessons from mass screening in a nursing home Gender Differences in Patients With COVID-19: Focus on Severity and Mortality Polyhandicap and aging Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis Emerging health challenges for children with physical disabilities and their parents during the COVID-19 pandemic: The ECHO French survey The authors state that they have no conflict of interest.